Phase I/II study of the TLR3 agonist poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 vg in patients with melanoma.
Rachel Lubong Sabado
No relevant relationships to disclose
Anna C. Pavlick
No relevant relationships to disclose
Sacha Gnjatic
No relevant relationships to disclose
Patrick Alexander Ott
No relevant relationships to disclose
Farah Hasan
No relevant relationships to disclose
Meredith Spadaccia
No relevant relationships to disclose
Isabelita Vengco
No relevant relationships to disclose
Rose Marie Holman
No relevant relationships to disclose
Caroline Muren
No relevant relationships to disclose
Crystal Escano
No relevant relationships to disclose
Ethel Yepes
No relevant relationships to disclose
Claire Stein
No relevant relationships to disclose
Achim A Jungbluth
Employment or Leadership Position - Ludwig Institute for Cancer Research
Linda S. Pan
Employment or Leadership Position - Ludwig Institute for Cancer Research
Ralph Rudolph Venhaus
Employment or Leadership Position - Ludwig Institute for Cancer Research
Nina Bhardwaj
No relevant relationships to disclose